RISING health care costs could lead to tighter government price controls, a Fitch Group unit said, creating headwinds for pharmaceutical companies and speeding up a shift toward cheaper generics. “The ...

Sales of weight loss medicines like Ozempic and Mounjaro have skyrocketed in South Africa in recent years. However, they remain too expensive for most people who might benefit from the jabs. Spotlight ...

Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s blockbuster weight-loss drug ‌Wegovy at a competitive price that could be up to 60% lower than the branded ...

In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal Court ruling that blocks local generics maker ...

After a decade of Lupin recovering in the corporate equivalent of an ICU, DBG (Desh Bandhu Gupta) did not mistake the consolation of having avoided disaster for good fortune. The decade since 1993 had ...

JDK 26 moves to general production availability. This short-term release is backed by six months of Premier-level support. Java Development Kit (JDK) 26, the latest standard Java release from Oracle, ...

Jennifer Christian-Herman ( [email protected]) is associate director, Health Services Research, at Cerner Health Insights in Beverly Hills, California. Matthew Emons is a principal investigator there, ...

Oral anti-obesity formulations will be the next growth lever in Danish drugmaker Novo Nordisk's India strategy, following the 2025 launches of its blockbuster diabetes and obesity brands Ozempic and ...